Overview

• The Justice Department has issued more than 20 subpoenas to doctors, clinics and major drug manufacturers as part of investigations into alleged healthcare fraud, false statements and drug misbranding in gender-affirming care for minors.
• The subpoenas build on President Trump’s January executive order to cut federal support for youth transition services and Attorney General Pam Bondi’s April memo directing prosecutors to apply female genital mutilation statutes against providers.
• The Federal Trade Commission convened a workshop on deceptive practices in gender-affirming care and launched a Section 5 consumer-protection inquiry with plans to solicit public comments.
• Several leading pediatric centers, including Children’s Hospital Los Angeles and UPMC Pittsburgh, have suspended or closed youth transition clinics in response to the increased federal scrutiny.
• Major medical associations such as the American Medical Association and the American Academy of Pediatrics maintain that gender-affirming treatment is evidence-based and warn that restricting access could harm transgender youth’s wellbeing.